Min Chen

Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model

W. Sadee, K. Schilling, J. Oberdick, 2020, bioRxiv.

Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats

J. Byrd, S. Kulp, Dasheng Wang, 2020, The AAPS Journal.

PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

Logan A. Walker, J. Byrd, R. Bundschuh, 2021, Blood.

Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans

S. Kulp, M. Phelps, C. Coss, 2021, JCSM rapid communications.

The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer

M. Dillhoff, S. Kulp, G. Behbehani, 2021, International journal of molecular sciences.

Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing

C. Hofmeister, M. Phelps, C. Coss, 2021, European Journal of Drug Metabolism and Pharmacokinetics.

Decoupling FcRn and Tumor Contributions to Elevated Immune Checkpoint Inhibitor Clearance in Cancer Cachexia.

S. Nimmagadda, Min Chen, Justin Thomas, 2023, Pharmacological research.